Skip to content

Development and validation of an instrument for assessing the disease activity in inflammatory arthritis

Development and validation of an Ama instrument for assessing the disease activity in Amavata ( Rheumatoid Arthritis) - DVAIDAA

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2022/04/042098
Enrollment
100
Registered
2022-04-22
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M059- Rheumatoid arthritis with rheumatoid factor, unspecified

Interventions

None listed

Sponsors

State Ayurvedic College and Hospital Lucknow
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Diagnosable as aamvata as per ayurvedic criteria and RA as per ACR criteria. 2.Having the symptoms for not less than 3 months. 4.Should not have taken any long acting steroids or disease modifying anti rheumatic drugs in past three months which may have modified the status of ama related features. 5. Should not have taken any NSAIDS or short acting steroids during past 12 hours from the time of actual interrogation.

Exclusion criteria

Exclusion criteria: 1. Patients having any other joint pathology besides RA(amavata). 2. Patients having ama related systemic pathology eg. obesity, hypothyroidism, diabetes,hepatostetosis, etc. to rule out this every prospective participants will be screened by Random Blood sugar, BMI, TSH, and serum alkaline phosphatase.

Design outcomes

Primary

MeasureTime frame
Development of an Ama assessment instrument for its use as a disease activity indicator in patients of Amavata ( RA)Timepoint: 6 months

Secondary

MeasureTime frame
1. Assessing the reliability of the instrument 2. Assessing the validity of the instrument with various standard disease activity scores, markers and patient related outcome measures in RA like ESR, CRP, DS 28 score , patient assessment of pain on VAS scale, brief PHQ, HAQ, FACIT-F Score 3. To see the feasibility of Ama score as a patient related outcome measure ( PROM) to evaluate the therapeutic benefits of a given ayurvedic intervention used in Ama related joint pathology. Timepoint: 6 months

Countries

India

Contacts

Public ContactSanjeev Rastogi

State Ayurvedic College and Hospital, Lucknow

rastogisanjeev@rediffmail.com9415022955

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026